Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys
Spread across 7,000 square feet, the Bengaluru facility is positioned as a purpose-built clinical prevention centre focused on identifying silent, life-threatening diseases in asymptomatic individuals
The innovation is particularly suited for bone and cartilage repair
The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
Subscribe To Our Newsletter & Stay Updated
